ACTIVE SESSION TAPE Biotechnology $89M Cap Quant: HOLD

Why Is Pliant Therapeutics, Inc. (PLRX) Stock Down Today?

Updated Nov 21, 2026 5:15 AM ET · Prev Close $0.62

Pro Workspace
Last Session Price
$0.60 -4.02%
-$0.02 vs $0.62 prior close
Intraday Range
$0.57 – $0.61
Open $0.60
Relative Volume
2.10x Avg
933,401 sh
52-Week Range
$0.57 – $1.67
Benchmark Alpha
-0.38% vs SPY
+1.65% vs QQQ
20-Session Trend -30.0%

Session Regime & Catalyst Assessment

68% Signal Conviction
SECTOR 68% Driver Weight

Pliant Therapeutics, Inc. Pulling Back 4.02% on 2.10x Relative Volume

Pliant Therapeutics, Inc. (PLRX) is pulling back 4.02% (-$0.02) to $0.60 on 2.10x average session volume. Relative to benchmarks, PLRX is trading in line with the S&P 500 (-0.38% alpha). 14-day RSI stands at 15.5, keeping momentum in a oversold regime.

NEWS 70% Weight
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Fortify, a Phase 1b indication expansion trial of Pln-101095, continues strong enrollment Pliant s proprietary selective, targeted, integrin-mediated delivery platform demonstrates encouraging initial preclinical results

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.60) trades relative to 20-day SMA ($0.78) and 50-day SMA ($0.92).

Volume Confirmation
HIGH VOLUME (2.10x) Distribution
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

PLRX trading in line with the S&P 500 (-0.38% alpha)
PLRX Session
-4.02%
$0.60
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: -0.38% Alpha vs QQQ: +1.65% Alpha vs XLV: -3.90%

Recent PLRX Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.57
Short-term support band
Upper Bound
$0.63
Short-term resistance band
Key Inflection Level
$0.57 (session support)

Monitor volume expansion above 1.5x RVOL around $0.57 (session support) for directional breakout confirmation.

Technical Regime (PLRX)

BEARISH MA TREND
RSI (14)
15.5
Oversold
20-Day SMA
$0.78
Below 20d
50-Day SMA
$0.92
Below 50d
MACD Signal
Bearish
MACD -0.08
ADX (14)
47.2
Strong trend
10d Momentum
-0.21
Soft 10-day momentum

Retail & Crowd Sentiment

Bearish
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

A bullish trader on StockTwits expressed excitement about $PLRX, asking why the stock isn't gaining more attention as a potential next runner.

Reddit communities: 1 comment (Bearish)

About Pliant Therapeutics, Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (Pln-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Sector
Healthcare
Market Cap
$89M
Employees
171

Get Instant PLRX Catalyst Alerts

Receive an email alert when PLRX triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

PLRX Session & Catalyst FAQ

Why is PLRX stock down today?

Pliant Therapeutics, Inc. (PLRX) is pulling back 4.02% (-$0.02) to $0.60 on 2.10x average session volume. Relative to benchmarks, PLRX is trading in line with the S&P 500 (-0.38% alpha). 14-day RSI stands at 15.5, keeping momentum in a oversold regime.

Is PLRX stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 2.10x relative volume (high participation). Our multi-factor model currently rates PLRX as HOLD. Review full valuation, quality, and timing signals on the PLRX Buy or Sell Decision Brief →

What is PLRX's intrinsic value and expected trading range?

At $0.60, PLRX's modeled 1-to-3 session range is $0.57 – $0.63, with a key inflection level at $0.57 (session support). Compare current price against multi-year cash flow projections in the PLRX Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for PLRX?

RSI at 15.5 indicates oversold conditions — watch for mean-reversion support. PLRX trades at $0.60 relative to its 20-day SMA ($0.78) and 50-day SMA ($0.92), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs